Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

NCT02961998 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Celecoxib
DRUG: Sorafenib

Sponsor

Sun Yat-sen University